P294 Using of bereitschaftspotentials and polymiography recordings as a fundamental diagnostic key of an uncommon type of movement disorder. Case report of a spinal-generated movement disorder at sleep onset causing severe insomnia

2017 ◽  
Vol 128 (9) ◽  
pp. e272
Author(s):  
Vizmary Montes-Peña ◽  
Jose Luis Boada-Cuellar ◽  
Sara Sánchez-Valiente ◽  
Diego Rodríguez-Mena
PM&R ◽  
2017 ◽  
Vol 9 ◽  
pp. S257-S257
Author(s):  
Ryan A. Menard ◽  
Brandon Barndt ◽  
Ernesto Cruz ◽  
Katie Hatt

Author(s):  
Eren Gozke ◽  
Boran Can Saraçoglu ◽  
Mustafa Eser ◽  
Aylin Reyhani ◽  
Pelin Dogan Ak

2020 ◽  
Vol 37 (2) ◽  
pp. 350-351
Author(s):  
Sandra Oska ◽  
Allison Zarbo ◽  
Marla N. Jahnke

1998 ◽  
Vol 56 (3B) ◽  
pp. 655-657 ◽  
Author(s):  
ROSANA S.C. ALVES ◽  
FLÁVIO ALÓE ◽  
ADEMIR B. SILVA ◽  
STELLA M. TAVARES

Rhythmic movement disorder, also known as jactatio capitis nocturna, is an infancy and childhood sleep-related disorder charactherized by repetitive movements occurring immediately prior to sleep onset and sustained into light sleep. We report a 19-year-old man with a history of headbanging and repetitive bodyrocking since infancy, occurring on a daily basis at sleep onset. He was born a premature baby but psychomotor milestones were unremarkable. Physical and neurological diagnostic workups were unremarkable. A hospital-based sleep study showed: total sleep time: 178 min; sleep efficiency index 35.8; sleep latency 65 min; REM latency 189 min. There were no respiratory events and head movements occurred at 4/min during wakefulness, stages 1 and 2 NREM sleep. No tonic or phasic electromyographic abnormalities were recorded during REM sleep. A clinical diagnosis of rhythmic movement disorder was performed on the basis of the clinical and sleep studies data. Clonazepam (0.5 mg/day) and midazolam (15 mg/day) yielded no clinical improvement. Imipramine (10 mg/day) produced good clinical outcome. In summary, we report a RMD case with atypical clinical and therapeutical features.


2010 ◽  
Vol 19 (4) ◽  
pp. 347-348
Author(s):  
Mohammed Tauqeer Ahmad ◽  
Chun Wai Yip ◽  
Kumar M Prakash

1991 ◽  
Vol 3 (1) ◽  
pp. 1-4
Author(s):  
A.R. Van Gool ◽  
R.C. Van Der Mast ◽  
P. Moleman

SummaryA case report is presented of a 72 year old woman, who has been treated for a depression with amitriptyline. During the treatment an orofacial dyskinesia develloped. Data in the literature concerning a possible link between the manifestation of orofacial dyskinesia and treatment with antidepressants were mainly found to be case reports. A closer study of the total in all of 25 case reports reveals that the antidepressant is often at most one of more possible determinants of the movement disorder. Particularly, it was frequently noted that patients were treated with other drugs or that the use of other drugs was not specified. A controverse exists in the literature whether or not a so called spontaneous orofacial dyskinesia is found in high frequency in elderly people. For clinical practice the advice is given that, in case an orofacial dyskinesia arises during antidepressant treatment, attention should be paid to other provoking factors in the first place.


2021 ◽  
Author(s):  
Vildan Çakır Kardeş ◽  
Selma Ertürk ◽  
Özge Saraçlı ◽  
Esra Acıman Demirel

Sign in / Sign up

Export Citation Format

Share Document